River Therapies is First in Greater Pittsburgh Area to Use Innovative I-PAS™ for Concussion and Vestibular Patients

River Therapies has added the FDA-cleared I-PAS™ to their practice as part of their River Concussion Group. I-PAS provides a range of OVRT tests and exercises.

PITTSBURGH, PA, US, February 21, 2019 /EINPresswire.com/ — River Therapies proudly announces they are the first physical therapy clinic in the Pittsburgh area to add an I-Portal ® Portable Assessment System (I-PAS™) to their practice. The I-PAS, developed by Neuro Kinetics, Inc. (NKI), is a game-changing, neural functional assessment tool. It is portable, FDA-cleared, and looks much like a virtual reality system. River Therapies can now offer an extensive battery of Oculomotor (eye movement), Vestibular (balance) and Reaction Time (or OVRT) tests and exercises to help the professionals at River Therapies address a multitude of injuries such as concussions.

Over the last 19 years, River Therapies has grown to now offer a variety of services including physical therapy, occupational therapy, psychology, and social work. Founder and Director Cherie River became a speech therapist after her nephew was diagnosed with Down’s Syndrome. Her passion to help those as challenged as her nephew now encompasses: River Therapies, River Pediatric Therapies, River School Therapies, and River Concussion Institute. These practices treat adults, adolescents, and children in schools, homes, and clinics across the Greater Pittsburgh region.

The clinic will use I-PAS as part of its newly formed River Concussion Group, to address the needs of adult to school-aged children who suffer from mild traumatic brain injury (mTBI). River explained that their goal is to bridge the gap between clinic, schools, and work by creating a process that addresses all aspects of concussion treatment and rehabilitation. River Concussion Institute is unique in the sense that they incorporate speech therapy, occupational therapy, physical therapy, psychology, and counseling into the concussion treatment program as needed per patient. River does not consider the concussion as an isolated event, but rather looks at entire function of the person so that they can start enjoying life again!

“Our experience has taught us how to assess and clinically integrate new technologies. Being the first to integrate I-PAS into our clinical practice provides our patients with the most clinically advanced, neuro-functional assessment tool, allowing River Concussion to design and implement the most appropriate and beneficial treatment possible for our clientele ” said River. “We are going to use it for baselines, for rehabilitation, and for post-treatment and post-season assessments.” She went on to explain that, having observed I-PAS first hand, nothing else provides the insight and neuro-functional measurements that Rivers Concussion and its clientele will be able to get with I-PAS. This puts Rivers’ practitioners in a unique position to design and implement the most powerful treatment plans.

Dr. John Schneider, a Physical Therapist at River Therapies, echoed River’s excitement about the inclusion of I-PAS in their treatment plan. "I couldn't be more excited to use the I-PAS system,” Dr. Schneider said. “It is especially valuable to me as I now have a way to determine if the interventions I choose for my patients are effective, or if I need to try a different approach. Our top priority is getting our patients better and back to doing what they love, and now we have a tool to let us know when and how we are achieving that goal." The objectivity of the data the device provides was also cited as a key benefit in comparison to alternative assessment tools, which are complementary and will be used when indicated to provide additional insight into a patient’s health condition.

NKI has supplied comprehensive neuro-functional diagnostic and assessment tools to professionals around the globe for more than three decades. The U.S. Food and Drug Administration (FDA) cleared fourteen oculomotor, vestibular, and reaction time tests on NKI’s I-PAS in November 2017. Since then, a series of exciting developments have taken place including Indy Racing League’s, LLC (INDYCAR), announcement to include I-PAS as part of their concussion evaluation protocol. Also, in June 2018 it was announced that NKI’s I-Portal™ technology, including I-PAS, was used to test and confirm inner-ear damage suffered by U.S. Diplomats to Cuba.

ABOUT NKI

Neuro Kinetics, Inc. (NKI) is the leader in clinical eye tracking and non-invasive neuro-functional diagnostics and monitoring. Abnormal eye responses have been connected to more than 200 diseases and medical conditions. With 24 issued patents and over 150 installations, NKI’s FDA-cleared I-Portal® devices are sold to physical therapists, audiologists, ENT’s, neurotologists, neuro-chiropractors, neuro-ophthalmologists and neurologists around the globe. The company's cleared diagnostic platforms include the I-PAS® (I-Portal® Portable Assessment System), I-Portal® NOTC (Neuro-Otologic Test Center), I-Portal® VNG, (Video Nystagmography) and I-Portal® VOG (Video Oculography), along with related accessories, software, training and support services.

Concussions, as mTBI’s are widely known, are an increasing public health concern. The need for an objective diagnostic device has made health care practitioners eager for a system that can measure concussion symptoms acutely and over time with speed, precision and reliability. Recent third-party research initially indicates a battery of OVRT (oculomotor, vestibular, and reaction time) tests, in combination with NKI’s I-Portal devices, can support a more accurate diagnosis of mTBI (concussion) symptom measurement both acutely and during convalescence. Please refer to NKI’s website and the resources page for papers reporting on I-Portal’s role in various concussion studies. NKI is actively working toward gaining clearance for its I-Portal® systems as an aid in the diagnosis of concussion based on this and other research. To learn more about NKI, please visit www.neuro-kinetics.com.

ABOUT RIVER THERAPIES

River Therapies is a dynamic private practice serving the Greater Pittsburgh Area of Pennsylvania comprised of River Therapies, River Pediatric Therapies, River School Therapies, and River Concussion Institute. They are staffed with a combination of over 50 outstanding, certified, and licensed Speech Language Pathologists, Developmental Therapists, Behavioral Therapists, Occupational Therapists, Physical Therapists, Psychologists, and Social Workers who treat adults, adolescents, and children. Services are provided in schools, homes, or within the Fox Chapel and Cranberry Clinics. Together they provide a comprehensive approach to intervention that focuses on the whole person because “Each step counts!”

From warm-water pool therapy to their especially designed and unique equipment, River has clients covered for an efficient and effective treatment plan. Pediatric, school-age services, in particular, are designed to heighten the sense of joy and accomplishment and to optimize the benefits of the natural environment. This is achieved by consulting in the child's school, home, preschool, or day care, and by helping their teachers, caregivers and family members to become a part of the process in reaching the child's goals. Combining nearly 20 years of experience with friendly and caring service, River Therapies focuses on your therapy needs in a positive and fun atmosphere! To learn more about River Therapies, please visit Riverpediatric.com.

Cherie River
River Therapies
+1 412-767-5967
email us here


Source: EIN Presswire

Helping Bile Duct Cancer Patients Find Specialists Nationwide

The Cholangiocarcinoma Foundation and Komodo Health Offer a First of Its Kind Interactive Map Connecting Patients and Doctors

SALT LAKE CITY, UT, USA, February 21, 2019 /EINPresswire.com/ — The Cholangiocarcinoma Foundation (CCF) has partnered with Komodo Health to create an interactive map for patients to find healthcare providers experienced in cholangiocarcinoma, nationwide. Patients may access CCF’s Specialist Finder here.

Cholangiocarcinoma, a cancer of the bile ducts, is often labeled a silent disease because many times the signs and symptoms go unnoticed until the cancer is in the advanced stage. Even when early signs and symptoms become known, they may be vague and easily attributed to another disease. Approximately 9,000 new cases are diagnosed each year—and these numbers are growing as cholangiocarcinoma has the second highest rising incidence rate amongst all cancers.

“Our patients struggle to find healthcare providers that provide the best standards of care for cholangiocarcinoma,” Stacie Lindsey, CCF Founder and President said. “Komodo Health’s healthcare map creates access for CCA patients to healthcare providers that are experienced with cholangiocarcinoma” Stacie continued.

Komodo Health and the Cholangiocarcinoma Foundation began their partnership in May of 2018. The agreement allows the Cholangiocarcinoma Foundation to access disease-specific insights to help get cholangiocarcinoma patients the right care at the right time.

“Specialist Finder will connect patients with the best standards of care and reduce the burden of this deadly disease.” Said Dr. Aswin Chandrakantan, Head of Product and Chief Medical Officer of Komodo Health.

Jordan Giles
Cholangiocarcinoma Foundation
+1 888-396-6731
email us here


Source: EIN Presswire

Intermountain Healthcare Reduced Number of Opioid Pills Prescribed by 3.8 Million in 2018

As part of its ongoing opioid-reduction initiative, Intermountain’s 2019 goal is to reduce opioid tablets for acute pain by an additional five percent

Utah has great coalitions that are coming together for the safety of our families, our friends, and our communities.”

— Lisa Nichols, Intermountain Community Health executive director

SALT LAKE CITY, UTAH, USA, February 21, 2019 /EINPresswire.com/ — Intermountain Healthcare reduced the number of opioid tablets prescribed to patients in acute pain by 3.8 million in 2018, a step that’s helping to reduce the risk of opioid dependency and misuse in Utah.

Intermountain has made opioid reduction a top priority, and the dramatic drop in opioid tablets prescribed by Intermountain clinicians in 2018 means the system cut opioid prescriptions by more than 30 percent last year. Acute pain is categorized as short-term pain that typically accompanies events like a broken arm or a surgery.

“We knew these would be lofty goals and we’re encouraged by the reduction in opioid tablets and the success of our other opioid-reduction efforts. We knew these were the right steps to take,” said David Hasleton, MD, Intermountain Healthcare’s associate chief medical officer. “We’re continuing our focus to implement appropriate evidence-based opioid treatments, provide alternative forms of pain control for our patients, and educate providers and the public about the safe use of opioid medications.”

Related accomplishments in Intermountain’s opioid-reduction efforts:

• Intermountain exceeded its goal to increase medically-assisted treatment for opioid use disorders by more than 10 percent.

• Intermountain reduced by 29 percent the number of patients prescribed both opioids and benzodiazepines, a medication commonly used to treat anxiety and other psychological conditions. The combination of these two medications could put patients at risk for suppressed breathing.

As part of its ongoing opioid-reduction initiative, Intermountain’s 2019 goal is to reduce opioid tablets for acute pain by an additional five percent. Intermountain will also continue to increase access to medication-assisted treatment for opioid dependency and continue to advance opioid co-prescribing, which allows pharmacists, as well as physicians, to provide opioid-reversing drugs that can save the lives of people who overdose.

The state of Utah has made significant strides in addressing the national opioid epidemic. The Centers for Disease Control and Prevention reported in August that Utah was one of a few states that saw a decline in opioid-related deaths.

The CDC reported a near 12 percent reduction in deaths in Utah from January 2017 to January 2018. Efforts by providers such as Intermountain, and increased access to the opioid-reversing drugs naloxone and Narcan, have contributed to this reduction.

Intermountain’s efforts to reduce opioid misuse also includes medication disposal and collaborating with state, local governments, and community partners through the “Use Only As Directed” public awareness campaign. More information on public awareness messaging can be found at www.useonlyasdirected.org.

Intermountain pharmacy drop-boxes have received over 26,000 pounds of medication since February 2015. Intermountain has also helped give out more than 1,700 naloxone kits. Intermountain pharmacies also offer naloxone kits for purchase without a prescription and the system has helped to fund additional kits for Utah Naloxone, which is a coalition of prescribers, pharmacists, public health workers, recovery advocates, and people who’ve lost loved ones to the opioid epidemic.

“We understand it takes all of us working together to reverse the opioid epidemic. Utah has great coalitions that are coming together for the safety of our families, our friends, and our communities,” said Lisa Nichols, Intermountain Healthcare’s Community Health executive director. “We’re encouraged by our successes so far, but we’re not where we need to be yet. We’re committed to continuing the fight against opioid misuse and abuse.”

Intermountain Healthcare is a Utah-based not-for-profit system of 23 hospitals, 170 clinics, a Medical Group with some 2,300 employed physicians and advanced care practitioners, a health insurance company called SelectHealth, and other health services. Intermountain is widely recognized as a leader in transforming healthcare through evidence-based best practices, high quality, and sustainable costs. For more information about Intermountain, visit intermountainhealthcare.org.

Daron Cowley
Intermountain Healthcare
+1 801-442-2834
email us here


Source: EIN Presswire

“Overdosed” Documentary Screening in Clearwater Brings Human Scale to Drug Crisis

Kimmie Lynn Markwood (center) answers questions from the audience as ‘Overdosed’ director Mary Sue Connolly (left) and producer (right) look on. ‘Overdosed’ chronicles the effect that the opioid drug crisis had on three small communities in West Virginia.

'Overdosed' is a story of a small town, but thousands of towns across the country fell victim to the same fate. It's a small-town-story that hints at the bigger picture.”

— Mary Sue Connolly, Director of "Overdosed"

CLEARWATER, FLORIDA, US, February 21, 2019 /EINPresswire.com/ — The opioid crisis was in the hearts and minds of the 100 people who attended a special screening of the documentary “Overdosed” on February 9th at Clearwater’s Fort Harrison. The documentary is a tour-de-force by director Mary Sue Connolly, which looks behind the startling figures of opioid abuse in West Virginia and the root causes of the crisis.

“I lost my beloved nephew to an overdose,” said Mary Sue Connolly, the director of the film. “This loss awakened me to an immense problem across the country and I was determined to find out what gave rise to this deadly scourge. As I said to my sister at the time; ‘I will keep walking over the hot coals of West Virginia until I find out what happened to Paul.’”

At the same time, Kammie Lynn Markwood, (who is featured in ‘Overdosed’), was experiencing the scourge first-hand. After suffering from addiction and turning to dealing, it was her own near-death by overdose that showed her she needed to change her life and re-make her community.

“Before the pill mills arrived, West Virginia was warm summer nights, bonfires, fishing, camping, ATV riding, lots of dirt and laughter,” said Markwood. “We were a hardworking, fun loving, happy group of people. But now, this is not the place I grew up. This is not the place I once loved – I stay because I have so much family here – including siblings, nieces, a nephew, and cousins – who can’t leave. Since I can't move them, I am determined to do everything in my power to give them a better, safer future.”

Markwood has since founded West Virginians for Change and is helping addicts get into rehab. Both Markword and Connolly first ran into resistance, but this did not stop them from moving forward.

“Making the film was a risky endeavor,” said Connolly. “We found ourselves in compromising situations, but there was never even a flicker of doubt about what we had to do. Overdosed is a story of a small town, but thousands of towns across the country fell victim to the same fate. It's a small-town-story that hints at the bigger picture.”

After screening the film, Connolly and Markwood joined their executive producer for a Q and A about the making of the film. One question was how will others be able to see the film?

Connolly and the film’s producers will continue to make the film festival circuit with ‘Overdosed’ and will then distribute the film on other channels. Residents in Pinellas County will be able to see the film at 4:00 on March 31st at Blur in downtown Dunedin, as a special presentation by the Dunedin International Film Festival.

The February 9th Screening was sponsored by the Concerned Businessmen’s Association of Tampa Bay, Consumer Energy Solutions, and MGE Management Experts.

The Fort Harrison is the international religious retreat for the Church of Scientology Flag Service Organization.

“We were very proud to show this film,” said Lisa Mansell, the Public Affairs Director for the Church. “Humanitarian L. Ron Hubbard wrote, ‘Research has demonstrated that the single most destructive element present in our current culture is drugs,’ and we see evidence of this every day. Educating others on this issue is something that we can do to help."

To learn more about future screenings of ‘Overdosed’, or to schedule a screening in your area, please go to https://www.overdosedfilm.com/.

ABOUT THE FORT HARRISON

Since completing construction in 1926, the Fort Harrison has been the home to many events for charitable organizations. The latest owner, the Church of Scientology, completed a top to bottom restoration of the Fort Harrison in 2009, and since then has hosted over 400 community events there. Scientology is an applied religious philosophy, founded by L. Ron Hubbard. The Church makes its facilities available to non-profit groups as a service to the community.

Pat Harney
Church of Scientology Flag Service Organization
727-467-6860
email us here


Source: EIN Presswire

SMi’s Pharma Microbiology West Coast 2019 chair and speakers announced

Micro WC brochure cover

Pharmaceutical Microbiology West Coast is back after a successful event in 2018. This year the confex is at Hyatt Regency Mission Bay, USA on June 5-6, 2019.

SAN DIEGO, CALIFORNIA, UNITED STATES , February 21, 2019 /EINPresswire.com/ — SMi's 3rd Annual Pharmaceutical Microbiology West Coast conference and exhibition is sponsored by: Associates of Cape Cod, bioMérieux, Bioscience International, Charles River, DuPont, FujiFilm and Microbiologics

I am pleased to announce the Chair for the conference Ms. Ziva Abraham, CEO at Microrite, who will be joining us again due to the positive feedback received from past attendees.

Ziva has 25+ years of academic, research, clinical and industrial experience in microbiology and quality assurance. She received her master’s degree in microbiology with a focus on mycology and has conducted research on developing microbial Insecticides using entomogenous bacteria and fungi for her PhD degree. At present she is the CEO and Founder of Microrite, Inc., a California based consulting firm providing consulting and training services to pharmaceuticals, biotechnology, medical devices and in vitro diagnostics in the areas of quality assurance, quality control, microbiology, and validation.

As well as chairing the 2-day conference, Ziva will also be leading one of the two pre-conference workshops on 'Assessing a Holistic Approach to Microbial Contamination Control' details below.

EXPERT MICROBIOLOGY SPEAKERS INCLUDE:

IRVING FORD, Head of CAR T QC Laboratories, Celgene Corporation
Irving has over 28 years of QA/QC experience in pharmaceutical/biotechnology and cell/gene therapies industries.
Currently, Irving is working on a task force for creating an ISO Standard for apheresis collection. Irving is also co-authoring a White Paper for appropriate microbiological controls for ATMPs manufacturing.
Irving will be presenting a keynote session on 'Just in time release of CAR-T Cell therapies' on day one.

FRIEDRICH VON WINTZINGERODE, Senior Manager gASAT Microbiology, Global QC, Roche Diagnostics Gmbh
He is Head of Roche-Genentech global Endotoxin Expert Group and Roche-Genentech global SME on microbial impurity contaminations and LER. He joined Roche in 2001 working as Micro lab Manager and Senior Manager on various topics (environmental monitoring, biochemical cleaning analytics, microbiological IPC and analytics for release, endotoxin testing, LER).
Friedrich will be presenting a spotlight session on ‘Low Endotoxin Recovery (LER) on day one.

ANITA BAWA, Quality Control Director, Bayer Healthcare
Anita has 20 years of experience in the biotechnology and blood bank industries.
In 2012, she joined Bayer to manage the Microbiology and Virology groups, currently manages Quality Control Microbiology/Environmental Monitoring/Cell Biology/Virology departments and oversees the operations, method validation, microbial identification, and discrepancy groups.
Anita will be speaking on ‘Investing Sterility Failures’ on day one.

LUCIA CLONTZ, Quality Director, Xellia Pharmaceuticals
Dr. Clontz has more than 30 years of industry experience in quality, pharmaceutical microbiology, laboratory management, operational excellence initiatives, and training. Dr. Clontz is a published author, speaker, and workshop leader at both national and international conferences, and in 2004, she received the PDA’s Distinguished Editor/Author award.
Lucia will be presenting an opening address on day one on ‘Strategic approaches to contamination control’.

HEIDI ANDERSON, Principal Scientist, Microbiology, Abbott
After graduating from the University of Wisconsin with a degree in Medical Microbiology and Immunology she began her career with Abbott’s Diagnostics Division and has continued to work there for nearly 15 years.
Heidi will be speaking on ‘The Conundrum of Microbial Identification’ on day one.

FARNAZ NOWROOZI, Scientist and Manager, Genentech, Inc Farnaz Nowroozi
Farnaz is an SME for Low Endotoxin Recovery topics and a key member of Endotoxin Expert Group at Roche-Genentech.
Farnaz will be speaking on spotlight session on 'New Endotoxin Testing Methods – A mass Spectrometry Based Approach'

For the full agenda and speaker line-up visit the website to download the brochure here – http://www.pharma-microbiology-usa.com/PR1

The event is CPD accredited.

Part of the conference there will also be two interactive half day pre-conference workshops taking place on June 4th, 2019

WORKSHOP A – 08:30AM – 12:30PM
Assessing a Holistic Approach to Microbial Contamination Control
Led by: Ziva Abraham, CEO, Microrite

WORKSHOP B – 1.30PM – 5.30PM
Reviewing the Road Map to a Holistic Approach to Microbial Impurities, Endotoxins and LER
Led by: Friedrich von Wintzingerode, Senior Manager gASAT Microbiology, Global QC, Genentech & Farnaz Nowroozi, Scientist and Manager, Genentech

If you would like to attend as a delegate at this event take full advantage and save US$400 for the 2-day conference (standard price is at US$1999). Register at http://www.pharma-microbiology-usa.com/PR1

________________________________________
Sponsored by: Associates of Cape Cod, bioMérieux, Bioscience International, Charles River, DuPont, FujiFilm & Microbiologics

Interested in sponsoring, exhibiting or speaking at this event?
Contact Alia Malick, Director, on +44 (0) 20 827 6168 or email amalick@smi-online.co.uk
________________________________________

For media enquiries, contact Simi Sapal on +44 (0) 20 7827 6000 or ssapal@smi-online.co.uk
Pharmaceutical Microbiology West Coast
June, 5 – 6 June 2019
Hyatt Regency Mission Bay Hotel, CA, USA
http://www.pharma-microbiology-usa.com/PR1
#SMiPharmaMicroUSA

—- END —-
About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Simi Sapal
SMi Group
+44 20 7827 6000
email us here


Source: EIN Presswire

TEENS LEARN THE TRUTH ABOUT MARIJUANA AT DRUG FREE WORLD PRESENTATION

Foundation for a Drug Free World Florida Chapter volunteers meet to coordinate presentations on the Truth About Drugs Program to schools and groups all over the greater Tampa Bay area. To attend a seminar or book a lecture, please call 727-467-6962.

There is a misconception that because marijuana is a plant, it’s ‘natural’ and so it’s harmless. But it’s not.”

— Julieta Santagostino,President of the FDFW Fl Chapter

CLEARWATER, FLORIDA, US, February 21, 2019 /EINPresswire.com/ — On February 13th, the President of the Foundation for a Drug-Free World Florida Chapter gave a drug education presentation to a group of teens in Tampa. The presentation included the facts about marijuana, including its role as a ‘gateway drug.’ Ten teens attended.

“There is a misconception that because marijuana is a plant, it’s ‘natural’ and so it’s harmless. But it’s not.” Said Julieta Santagostino the President of the Foundation for a Drug-Free World Florida Chapter. “Hemlock, a poisonous plant, is also ‘natural,’ but it can kill.”

“Marijuana is a drug like alcohol, cocaine or ecstasy,” said Santagostino. “And like these other drugs, it has side effects that can be harmful. There are 400 chemicals in Marijuana and the chemical that causes intoxication or the ‘high’ in users is called THC (short for tetrahydrocannabinol). THC creates the mind-altering effects that classifies marijuana as a ‘drug’.”

The seminar utilized materials from the Truth About Drugs program, including a booklet on Marijuana and an excerpt from the award-winning “Truth About Drugs” documentary.

These materials form the basis of a full anti-drug educational program that is available to educators at no cost.

“I learned a lot about drugs that I did not know,” said one student. “I am glad I came today to find out what marijuana actually does.”

To find out more about the effects of marijuana on the body you can get a free copy of the “Truth About Marijuana” information booklet.

The Florida chapter of the Foundation for a Drug-Free World also offers free seminars every Wednesdays at 7:00PM in their information center located at 41 N. Fort Harrison Ave in Clearwater. And provide free drug education materials, including 14 different booklets and a documentary DVD “Real People Real Stories.”

Anyone who would like more information or get a copy of the Truth about Drugs information booklets can visit the Foundation for a Drug-Free World information center at 41 N. Fort Harrison Ave or contact them at 727-467-6962 or email info.fl@drugfreeworld.org

The Foundation for a Drug-Free World is a non-profit organization that educates youth and the community on the truth about drugs so they can make the right decision to live drug-free. The Church of Scientology is a sponsor of the program making it possible for the Foundation to provide educational materials at no cost to educators, law enforcement and the community. Humanitarian and founder of Scientology, L. Ron Hubbard, said, “Drugs rob life of the sensations and joys which are the only reasons for living anyhow.”

Pat Harney
Church of Scientology Flag Service Organization
727-467-6860
email us here


Source: EIN Presswire

Shortening Fats Market 2019 Global Trends, Market Share, Industry Size, Growth, Opportunities and Forecast to 2024

WiseGuyReports.com adds “Shortening Fats Market 2019 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2024”

PUNE, INDIA, February 21, 2019 /EINPresswire.com/ — Summary

WiseGuyReports.com adds “Shortening Fats Market 2019 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2024” reports to its database.

This report provides in depth study of “Shortening Fats Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Shortening Fats Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

Global Shortening Fats market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Unilever
Bunge
NMGK Group
ConAgra
Zydus Cadila
Wilmar-International
Wilmar-International
BRF
Yidiz Holding
Grupo Lala
NamChow
Sunnyfoods
Cargill
COFCO
Uni-President
Mengniu
Yili
Brightdairy
Dairy Crest

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/3522532-global-shortening-fats-market-data-survey-report-2025

The global Shortening Fats market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Major Application
Major Type

Major applications as follows:
Confectionary
Ice Cream
Snacks
Bakery
Major Type as follows:
Soybean and Maize
Rapeseeds and Sunflower Seed
Palm and Palmkernel
Coconut and Linseed
Groundnut
Others

Regional market size, production data and Trade:
Asia-Pacific
North America
Europe
South America
Middle East & Africa

At any Query @ https://www.wiseguyreports.com/enquiry/3522532-global-shortening-fats-market-data-survey-report-2025

Major Key Points in Table of Content

1 Global Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.5 Scope of Regions/Countries
1.2 Global Market Size

2 Regional Market
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade

3 Key Manufacturers
3.1 Unilever
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Bunge
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 NMGK Group
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 ConAgra
3.4.1 Company Information
3.4.2 Product Specifications
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 Zydus Cadila
3.5.1 Company Information
3.5.2 Product Specifications
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 Wilmar-International
3.6.1 Company Information
3.6.2 Product Specifications
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 Wilmar-International
3.7.1 Company Information
3.7.2 Product Specifications
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 BRF
3.8.1 Company Information
3.8.2 Product Specifications
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9 Yidiz Holding
3.9.1 Company Information
3.9.2 Product Specifications
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10 Grupo Lala
3.10.1 Company Information
3.10.2 Product Specifications
3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.11 NamChow
3.12 Sunnyfoods
3.13 Cargill
3.14 COFCO
3.15 Uni-President
3.16 Mengniu
3.17 Yili
3.18 Brightdairy
3.19 Dairy Crest

4 Major Application
4.1 Confectionary
4.1.1 Overview
4.1.2 Confectionary Market Size and Forecast
4.2 Ice Cream
4.2.1 Overview
4.2.2 Ice Cream Market Size and Forecast
4.3 Snacks
4.3.1 Overview
4.3.2 Snacks Market Size and Forecast
4.4 Bakery
4.4.1 Overview
4.4.2 Bakery Market Size and Forecast

Buy NOW @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3522532

Continued….

Contact Us: sales@wiseguyreports.com

Ph: +1-646-845-9349 (US); Ph: +44 208 133 9349 (UK)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
646 845 9349 / +44 208 133 9349
email us here
["facebook", "twitter", "google", "linkedin"]
{"facebook"=>"", "twitter"=>"", "google"=>"", "linkedin"=>""}


Source: EIN Presswire

Soya Flour Market 2019 Global Trends, Market Share, Industry Size, Growth, Opportunities and Forecast to 2024

WiseGuyReports.com adds “Soya Flour Market 2019 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2024” reports to its database

PUNE, INDIA, February 21, 2019 /EINPresswire.com/ — Summary

WiseGuyReports.com adds “Soya Flour Market 2019 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2024” reports to its database.

This report provides in depth study of “Soya Flour Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Soya Flour Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

Global Soya Flour market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Ingredion
ADM
The Scoular Company
Sunopta
Anchor Ingredients
EHL Limited
EHL Limited
Diefenbaker Spice & Pulse
Blue Ribbon
Great Western Grain
Best Cooking Pulses
Bean Growers Australia

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/3522525-global-soya-flour-market-data-survey-report-2025

The global Soya Flour market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Major Application
Major Type

Major applications as follows:
Food & Beverages
Feed
Personal Care
Others
Major Type as follows:
Pea
Chickpea
Bean
Lentil

Regional market size, production data and Trade:
Asia-Pacific
North America
Europe
South America
Middle East & Africa

At any Query @ https://www.wiseguyreports.com/enquiry/3522525-global-soya-flour-market-data-survey-report-2025

Major Key Points in Table of Content

1 Global Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.5 Scope of Regions/Countries
1.2 Global Market Size

2 Regional Market
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade

3 Key Manufacturers
3.1 Ingredion
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 ADM
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 The Scoular Company
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Sunopta
3.4.1 Company Information
3.4.2 Product Specifications
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 Anchor Ingredients
3.5.1 Company Information
3.5.2 Product Specifications
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 EHL Limited
3.6.1 Company Information
3.6.2 Product Specifications
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 EHL Limited
3.7.1 Company Information
3.7.2 Product Specifications
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 Diefenbaker Spice & Pulse
3.8.1 Company Information
3.8.2 Product Specifications
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9 Blue Ribbon
3.9.1 Company Information
3.9.2 Product Specifications
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10 Great Western Grain
3.10.1 Company Information
3.10.2 Product Specifications
3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.11 Best Cooking Pulses
3.12 Bean Growers Australia

4 Major Application
4.1 Food & Beverages
4.1.1 Overview
4.1.2 Food & Beverages Market Size and Forecast
4.2 Feed
4.2.1 Overview
4.2.2 Feed Market Size and Forecast
4.3 Personal Care
4.3.1 Overview
4.3.2 Personal Care Market Size and Forecast
4.4 Others
4.4.1 Overview
4.4.2 Others Market Size and Forecast

Buy NOW @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3522525

Continued….

Contact Us: sales@wiseguyreports.com

Ph: +1-646-845-9349 (US); Ph: +44 208 133 9349 (UK)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
646 845 9349 / +44 208 133 9349
email us here
["facebook", "twitter", "google", "linkedin"]
{"facebook"=>"", "twitter"=>"", "google"=>"", "linkedin"=>""}


Source: EIN Presswire

Acclaimed USC Top Doc Says "Yes" to Operation:Scrubs Keynote Speaker Invite

Operation:Scrubs Symposium, May 6, 2019 – National Nurses Day – Marina Del Rey, CA

Dr. Nerses Sanossian, Associate Professor of Neurology

Dr. Nerses Sanossian, MD, Associate Professor of Neurology, Neurocritical Care, Neuroimaging, Vascular Neurology

Pamela Jane Nye, Executive Director, Operation:Scrubs / CEO, Neuroscience Nursing, Ltd.

Pamela Jane Nye Keeps Maverick Nurse Moniker – Recruits Legendary USC Neurologist/Associate Professor Dr. Nerses Sanossian as Operation:Scrubs Keynote Speaker

It’s exciting to appear before so many stroke nurses representing California’s major stroke hospitals, to talk about stroke future, and share the most recent developments in prehospital stroke care.”

— Sr. Nerses Sanossian

MARINA DEL REY, CALIFORNIA, USA, February 21, 2019 /EINPresswire.com/ — When combined, the words "Nerses," "Sanossian" and the initials "MD" have routinely enjoyed significant, specific and favorable search engine placement.

The combination of the words, “Pamela," "Nye," "Operation," and "Scrubs," however, have only recently become Google, Bing, and Yahoo search engine placement favorites.

What the two now have in common, is Operation:Scrubs: Dr. Nerses Sanossian will be Operation:Scrubs keynote speaker, and talk about "Development in Prehospital Stroke Care" to Pamela Jane Nye's stroke coordinator audience representing California’s 180+ Comprehensive, Primary and Stroke-Ready hospitals.

An industry legend in the world of neuroscience medicine, Dr. Sanossian is an Associate Professor with Board Certification in Neurology, Vascular Neurology and Neurosonology (neurovascular ultrasound) with current hospital affiliations including Keck Hospital of USC, USC Care Medical Group, Inc., USC Norris Cancer Hospital, and Verdugo Hills Hospital.

Dr. Sanossian’s specialization includes diagnosis and management of stroke, e.g., ischemic stroke, intracranial hemorrhage, cerebral vasculitis, stroke genetics, aneurysms, arteriovenous malformations (AVM). His research interests include the anti-inflammatory role of high-density lipoprotein cholesterol in cerebral atherosclerosis, vascular risk factors associated with cognitive impairment and dementia, also stroke and cerebrovascular disease in underserved and Latino populations.

He also has many “Teacher of the Year” accolades and is the recent recipient of the American Heart Association’s “new investigator award.”

Attracting a speaker with Dr. Sanossian’s credentials, let alone for an inaugural symposium with no prior history, is significant. When asked why Operation:Scrubs? Dr. Sanossian said “I've known and worked with Pam for many years. I said ‘yes’ because I want to support her continuing efforts to make a difference. This (Operation:Scrubs) symposium is innovative and exciting. It’s exciting to appear before so many stroke nurses representing California’s major stroke hospitals, to talk about stroke future, and share the most recent developments in prehospital stroke care."

According to Nye, she was admittedly surprised to receive Dr. Sanossian's email acceptance, explaining, "I know Dr. Sanossian keeps an incredibly busy and full schedule, and because of that, I was hesitant even to ask. Luckily I did ask, and with Dr. Sanossian as the keynote speaker, reinforces Operation:Scrubs having a high bar standard for providing quality, innovative and leading-edge continuing nurse education.”

Operation: Scrubs inaugural launch is May 6, National Nurses Day. "See a Nurse? Thank a Nurse!" is the theme and national challenge message.

Acting on that message, Operation:Scrubs takes place aboard FantaSea One, a 4-deck mega yacht in Marina del Rey, California. Furthermore, in addition to 8-hours of accredited continuing education, attending nurses receive a deluxe continental breakfast and a multi-choice soup-salad-dessert bar lunch. The symposium ends with a 2-hour sunset harbor cruise, including a hosted reception/hospitality party, gourmet buffet dinner, entertainment, and sponsor-provided swag-bag gifts to symposium attendees.

The Executive Director of Operation: Scrubs is Pamela Jane Nye. She's also the founder/CEO of Neuroscience Nursing, Ltd. On February 15th, Nye retired at the top of her 4-decade nursing career as the Stroke Coordinator/Clinical Nurse Specialist at UCLA Medical Center/Santa Monica. She will continue, however, as an Associate Professor at the UCLA School of Nursing.

Click Dr. Sanossian's Curriculum Vitae can be viewed by clinking his linked name above or viewed at https://operationscrubs.homestead.com/Sanossian_CV_2019.pdf

Chuck Foster
Operation:Scrubs, a DBA of Neuroscience Nursing, Ltd.
+1 800-627-6156
email us here
Visit us on social media:
Facebook
LinkedIn

FantaSea One, flagship of FantaSea Yachts, Inc., is the Official Venue of Operation:Scrubs Inaugural Symposium


Source: EIN Presswire

Author and Reverend Donna Andes to be Featured on CUTV News Radio

THOMAS, WEST VIRGINIA, UNITED STATES, February 21, 2019 /EINPresswire.com/ — Donna Andes says that from a very young age, the Lord was always drawing her closer to walk with Him. She was a Franciscan Sister who lived in a convent for 21 years, and they sent her to get a degree in Nursing. She is also a Reverend and Doctor of Philosophy and Theology (whose desire to know the Bible better brought her to Life Christian University.) She has tended to sick and elderly people, as an Operating Room Supervisor and at the Mountaintop Home Health Agency in Thomas, West Virginia. She worked with alcoholics and later as missionary, spending time in Africa and Cuba. There is no such thing as retirement for a Christian, she says, and she will never stop doing the Lord’s Work.

Donna is listed in Who’s Who and received the Elbert Nelson Lifetime Achievement Award. She is also a longtime member of Aglow International (that’s a-glow, as in glowing in His Light) and during the 50 years was president of a local chapter. She wrote her second book I Would Do it All Again, as an autobiography, but notes it is a great reference book for those having difficulties in marriage. A lot of problems, Donna believes, can be solved with God intercepting.

In her radio show Donna wants to talk about why she wrote her first book Know Thy Enemy. She will explain why it is so important to be aware of the spiritual realm around us. All the turmoil in the world can be addressed once we realize there is a devil, where he came from, the influence he has, and he is going around the world seeking whom and what he can devour. She wants to educate people by explaining how God created everything, and how they can improve their life and situation through prayer. This hinges on why she left the convent.

Donna preaches locally, conducts prayer meetings, and writes She is constantly writing to those in leadership positions, from the President to local government leaders. One day a week she answers the hotline for "Hope Marriage Center" through Christ in Action. Besides that, she is a part-time Network Marketer with Life Vantage that specializes in nutrigenomics. That word refers to nutrition and the body's genes to prevent aging and disease. The products are a new discovery and all-natural. The medical community is just catching on to what NRF1 and NRF2 are. The latter upgrades our cells to what they did back when we were born!

Donna wants to share how prayer can change us, our environment and even nations. To do that, she says, we need God's power. It begins when we invite Jesus into our heart, surrender our life to Him, and then ask to receive the fullness of the Holy Spirit. This enables us to pray with God's power and authority.

Don’t miss this inspiring speaker!

CUTV News Radio will feature Reverend Donna Andes in an interview with Jim Masters on Monday, February 25th at 4:00 pm EST

Listen to the Show on BlogTalkRadio

If you have questions for our guest, please call (347) 996-3369

For more information about Donna, visit her website: http://www.donnaandes.com

For more information about LifeVantage products visit https://donnaandes.lifevantage.com

Lou Ceparano
CUTV News
(631) 850-3314
email us here
Visit us on social media:
Facebook


Source: EIN Presswire